Skip to Content

93 8164 (Quetiapine Fumarate 300 mg)

Pill with imprint 93 8164 is Yellow, Capsule-shape and has been identified as Quetiapine Fumarate 300 mg. It is supplied by Teva Pharmaceuticals USA Inc..

Quetiapine is used in the treatment of bipolar disorder; generalized anxiety disorder; schizoaffective disorder; depression; schizophrenia (and more), and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Quetiapine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 8164

Quetiapine fumarate 300 mg 93 8164
Quetiapine fumarate 300 mg 93 8164
Quetiapine fumarate 300 mg 93 8164

Quetiapine Fumarate

Imprint:
93 8164
Strength:
300 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Atypical antipsychotics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA Inc.
Inactive Ingredients:
silicon dioxide
calcium phosphate dihydrate dibasic
hypromellose 2910 (15 mPa.s)
lactose monohydrate
magnesium stearate
microcrystalline cellulose
povidone k25
sodium starch glycolate type A potato
titanium dioxide
triacetin
ferric oxide yellow
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
42291-0699 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide